Olga Cortez, MD - LDN Use in Women's Health I (2019 Conference) (LDN, low dose naltrexone)

 

LDN 2019 Conference - Sunday Q&A (2019 Conference) (LDN, low dose naltrexone)

Presentations on the below and questions were asked in relation to:

 

Sarah Zielsdorf, MD, MS - Graves' Disease (2019 Conference) (LDN, low dose naltrexone)

Sarah Zielsdorf, MD discusses what Graves’ disease is, treatment strategies, related conditions and predisposing factors, and the work-up from a functional medicine standpoint

 

Pamela Smith, MD - LDN and Multiple Sclerosis (2019 Conference) (LDN, low dose naltrexone)

 

Michael Ruscio, DC - The Gut-Thyroid Connection, Profound but Under-Appreciated (2019 Conference) (LDN, low dose naltrexone)

 

Kent Holtorf, MD - Causes of Hashimoto's (2019 Conference) (LDN, low dose naltrexone)

Kent Holtorf, MD discusses Hasimoto’s thyroiditis at the LDN 2019 Conference. He discusses the mechanisms of thyroid dysfunction, causes and evaluation of Hashimoto’s thyroiditis, Hashimoto’s in obesity, and treatments of Hasimoto's
 

 

Harpal Bains, MBBS - The role LDN plays in the body's hormonal symphony: how a well-conducted orchestra enhances the efficacy of LDN (2019 Conference) (LDN, low dose naltrexone)

 

Harpal Bains, MBBS - Biodentical hormones+asthetic+lifestyle (2019 Conference) (LDN, low dose naltrexone)

Dr Harpal Bains, MBBS discusses the interaction between bioidentical hormones, aesthetics, and lifestyle. She talks on the major hormone, immune disorders, environmental toxins, nutritional effects, particularly cortisol. She presents a treatment approach including hormones, nutrients, and LDN.

 

Carrie Jones, ND, MPH - LDN and Cellular Hypothyroidism: When TSH is Normal but Reverse T3 is Elevated (2019 Conference) (LDN, low dose naltrexone)

Carrie Jones, ND, MPH discusses LDN and hypothyroidism at the LDN 2019 Conference. She discusses the thyroid hormone cycle, deiodinase enzymes that affect thyroid hormones, and LDN’s mechanism of action related to thyroid functioning.